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ABSTRACT
INTRODUCTION:
The increasing incidence of pre eclampsia necessitates its early detection and
intervention for a better  perinatal outcome. Doppler plays a significant role in antepartum
fetal surveillance. Early and accurate detection of abnormal doppler velocimetry  demands the
Obstetrician to plan accordingly and  thereby improving the perinatal outcome.
AIMS AND OBJECTIVES:
To study the association between pre eclampsia  and  abnormal doppler
velocimetry of  triple vessel Uterine artery, Umbilical artery and Middle
cerebral  artery.
Perinatal outcome with abnormal doppler velocimetry in patients with pre
eclampsia
MATERIALS AND METHODS:
All antenatal patients who deliver in the department of Obstetrics and
Gynaecology, Chengalpattu Medical  College and Hospital during the period of
febraury 2015 to September 2015. 200 Patients were taken for my study. Out of
which 100 belong to control group and 100 were in study group. Doppler
pattern was studied in Uterine artery, Umbilical artery and Middle cerebral
artery for all pre-eclampsia patients.
RESULTS:
Umbilical artery and middle cerebral artery doppler abnormality are a better
indicator of perinatal outcome.
In the study with uterine artery,  27% were found to have abnormal pattern
,27% with uterine artery high resistance and 28% showed uterine artery early
diastolic notch in study group.
With the study of umbilical artery in the study group, 55% were found to
have abnormal pattern, 56% with umbilical artery high resistance , 54% with
absent end diastolic flow and 29% with reversed end diastolic flow.
17% were found to have abnormal middle cerebral artery pattern among the
study group.
Cesarean section rate incidence was higher in the study group (43%)
compared with the control group (17%).
Neonatal mortality accounted to 8% which is similar to Mikovic study et all.
Those who have abnormal doppler velocimetry, there is an increased incidence
of still birth and IUD when compared to control group.
CONCLUSION:
APGAR rate for babies with abnormal Doppler velocimetry are low when
compared to control group. And also the incidence of neonatal complications
after birth is also increased with abnormal dopper velocimetry. The incidence
of caesarean section rate is increased among abnormal Doppler velocimetry.
Thus Doppler velocimetry is a major support for the conventional antepartum
surveillance especially in pre eclampsia.
Abnormal doppler velocimetry alarms the obstetrician to plan the pregnancy in
a tertiary care centre with a better NICU setup as it warrants   effective
monitoring of the patient and expert neonatal care
1INTRODUCTION
Pre eclampsia is defined as the presence of  systolic blood pressure more
than 140 mmhg and diastolic blood pressure more than 90 mmhg , along with
proteinuria  in pregnant women . It usually occurs after 20 weeks of pregnancy or
sometimes earlier when there is multi-fetal pregnancy or molar pregnancy.
The incidence is 5- 10 % of pregnancies. It is a pregnancy specific disease
and is associated with high maternal and fetal morbidity and mortality.
Berg and colleagues reported that 16% of 3201 maternal death in the united
states from 1991 to 1997 were complications of gestational  hypertension . During
this study, black women had 3% times higher mortality compared with the white
women.
The pathophysiology is characterized by a failure of  trophoblastic invasion
of  spiral arterioles, leading to the maladaptation of  maternal spiral arterioles which
is  associated with increased vascular resistance of the uterine artery and decreased
perfusion of the placenta.
Spiral arterioles plays an significant role in  pre eclampsia. The  structural
and physiological changes in the normal spiral arterioles may lead to the
development of  pre eclampsia.
The precise cause of the vascular endothelial dysfunction , an important
factor in  etiopathogenesis of pre-eclampsia remains unclear.
2The complications of severe pre eclampsia could be prevented by prompt
diagnosis of high risk cases, antenatal care and timely intervention.
Doppler plays a significant role in antepartum fetal surveillance. Early and
accurate detection of abnormal doppler velocimetry  demands the Obstetrician to
plan accordingly and  thereby improving the perinatal outcome.
3AIMS AND OBJECTIVES
To study the association between pre eclampsia  and  abnormal doppler
velocimetry of  triple vessel -Uterine artery, Umbilical artery and Middle cerebral
artery.
Perinatal outcome with abnormal doppler velocimetry in patients with pre
eclampsia.
4REVIEW OF LITERATURE
HISTORY
History of eclampsia starts from Hippocratic writings(430-330 BC). In the
year (384 – 322 BC) Aristotle  was the first to realise that the fetal nutrients are
transferred through the umblical cord , which is the only source of connection
between the mother and fetus. He also realised that the fetus is fully surrounded by
membranes. De-La Motte , in the year 1726, considered  that unless associated with
convulsions , the oedema is mostly benign.
In  18th century, the idea of proteinuria linked with eclampsia was identified
and  during the same period,  association between  oedema, headache and blurred
vision were also remarked.
In  19th century,  pre eclampsia was studied in a large manner. As a result of
these researches, hypertension was identified as an important factor in  pre
eclampsia. The triad of oedema, hypertension and proteinuria which often precedes
the convulsion was came to known as pre eclampsia.
In 1924,  renowned scientist Husselman identified that primigravida  is eight
times more prone to have eclampsia than multigravida. He also found that  there is a
six fold  increased risk of eclampsia in twin pregnancy.
In  1926- 1936, Herrick and co workers  found that the essential hypertension
is a highly associated  factor in  hypertensive disorders of pregnancy.
5Dickmann  in 1952,  found that when  hypertensive disorders are present in a
pregnant woman,  she might have either nephritis or essential hypertension.
Redman in  1991, attributed  preeclampsia to be an inadequate response of
the mother to  fetus.
Gill  in 1994, postulated  the familial nature in  pre eclampsia.
Christian Andreas Doppler and the Doppler theory:
The Doppler effect is “ apparent change observed  in the frequency of a
sound wave caused by relative motion between the source  and the observer”. The
Doppler effect applies only when the motion is directly towards or away between
the source and the observer. This was discovered by an Australian physicst &
Mathematician, “Christian Andreas Doppler”.
The  Seattle research team developed pulsed wave Doppler  equipment for
the first time. This research team was headed by Dennis Watkins, John Rein  and
Donald Baker. The project was started way back in 1966. Duplex instrumentation
was also first constructed by this Seattle team. Single transducer crystal does both
Doppler  and imaging function on a time-sharing basis. This is helpful for  the
operator to detect the target of Doppler insonation by the  Duplex Doppler
technique. This  discovery marks a milestone in the obstetric and gynaecological
field.
6Development of colour Doppler USG:
“Single line of  ultrasound beam transmission is interrogated in spectral
Doppler USG.. Hemodynamic information provided by the spectral Doppler
ultrasound which was based on the single dimension flow velocity had its own
limitations. This led  to  the discovery of two dimensional colour Doppler”.
The processing of Doppler ultrasound and signal  was based on the studies
done by ‘Angelson and Kristofferson team’ and ‘Namekawa et al and team’. The
former team used the sophisticated filtration technique applied in the radar system
of the target indicator motion. This technique removes the high amplitude/ low
velocity signals produced by the vessel wall and tissue movement. The latter team
discovered the auto co relation technique which used an auto co relator. This auto
co relator  has the ability to process the mean Doppler phase shift data from 2D
scan.
Entry of Doppler  Ultrasound in Obstetrics and Gynaecology:
“Fetal heart movements detection was the pioneered application by the
Doppler ultrasound in obstetrics.  Further  a non invasive continuous electronic fetal
heart rate  monitoring was discovered. This system utilise a continuous wave
Doppler ultrasound to determine the fetal heart rate from the fetal cardiac structures.
Drumm, Fitzgerald  and Mc Callum et al  reported the application of
Doppler velocimetry for the first time in obstetrics. This team was the first to
publish a renowned article. This publication lead to an era of intensive research
7using the Doppler velocimetry in assessing the different components in maternal
and fetal circulation.
Use of two dimensional colour Doppler flow mapping techniques in
obstetrics was reported by Devore and associates and Maulik and associates. In both
studies the  Doppler flow mapping was used to characterize the fetal cardiac flow
dynamics. Taylor et al  characterised the Doppler waves from  ovarian/uterine
arterial circulations using the  pulse duplex-Doppler instrumentation”.
8METHODOLOGY
In this study, antenatal pregnant women – Primigravida with Pre- eclampsia
were identified and who filled the criteria mentioned above were enrolled as study
group. And same number of normotensive patients were enrolled as control group.
For each patient, history as mentioned in the proforma was taken followed by a
general, physical, systemic and obstetric examination.
Ultrasound was done in these patients and doppler ultrasound of the uterine
artery,umbilical artery and Middle cerebral artery were noted.
Doppler ultrasound was done with duplex doppler system.
The patient was placed in supine position with left lateral tilt of 15 degree to
avoid caval compression.
UTERINE ARTERY:
Uterine artery was examined with the probe kept 3 cm medial to anterior
superior iliac spine and directed towards the lateral wall of the uterus. The cross
over of the uterine artery and the external iliac artery was identified and the sample
site was chosen. Waveforms were recorded from both uterine arteries.
UMBILICAL ARTERY:
Flow velocity waveforms were recorded from the free floating loops in mid
position. The diagnosis of absent end diastolic flow or reversed end diastolic flow
were made when same doppler patterns was demonstrated in three separate
sampling sites.
9MIDDLE CEREBRAL ARTERY:
Waveforms are recorded from MCA as it courses through the lateral sulcus.
Colour doppler is used to map at the circle of willis
10
RESULTS
TABLE 1
DISTRIBUTION OF CASES BASED ON AGE
Age Control Study
<20 yrs 6 5
20 - 30 yrs 91 93
> 30 yrs 3 2
In control group, 91% belong to age group 20-30 years, 3% were above 30
years and 3% were less than 20 years
In study group, 93% belong to age group 20-30 years, 2% were above 30
years and 5% were less than 20 years
FIG 1: AGE DISTRIBUTION
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TABLE 2
UTERINE ARTERY PATTERN DISTRIBUTION
UA pattern Control Study
Normal 100 73
abnormal 27
FIG 2: UTERINE ARTERY PATTERN DISTRIBUTION
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TABLE 3
UTERINE ARTERY PATTERN AND PERINATAL OUTCOME
Group APGAR5 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Normal 96 2 2 100
Study
Normal 69 (93.2%) 3 (15%) 1 (16.7%) 73
59.19 0.0001abnormal 5 (6.8%) 17 (85%) 5 (83.3%) 27
Total 74 20 6 100
Group NNC Death Without comp With comp Total Chi sq p
Control Normal 1 98 1 100
Study
Normal 1 (11.1%) 69 (94.5%) 3 (16.7%) 73
63.62 0.0001abnormal 8 (88.9%) 4 (5.5%) 15 (83.3%) 27
Total 9 73 18 100
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TABLE 4
UTERINE ARTERY HIGH RESISTANCE
UA HR Control Study
Absent 100 73
Present 27
FIG 3: UTERINE ARTERY HIGH RESISTANCE
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TABLE 5
UTERINE ARTERY HIGH RESISTANCE AND PERINATAL OUTCOME
Group Condition IUD Still birth Live born Total Chi sq p
Control Absent 1 1 98 100
Study
Absent 0 1 (50%) 72 (76.6%) 73
11.968 0.003Present 4 1 (50%) 22 (23.4%) 27
Total 4 2 94 100
Group APGAR1 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Absent 93 4 3 100
Study
Absent 48 21 (56.8%) 4 (26.7%) 73
39.04 0.0001Present 0 16(43.2%) 11 (73.3%) 27
Total 48 37 15 100
Group NNC Death Without
comp
With
comp Total
Chi
sq p
Control Absent 1 98 1 100
Study
Absent 1(11.1%) 68 (93.2%) 3 (16.7%) 72
60.08 0.0001Present 8(88.9%) 5 (6.8%) 15 (83.3%) 28
Total 9 73 18 100
15
TABLE 6
UTERINE ARTERY EARLY DIASTOLIC NOTCH
EDN Control Study
Absent 100 72
Present 28
FIG 4: UTERINE ARTERY EARLY DIASTOLIC NOTCH
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TABLE 7
EARLY DIASTOLIC NOTCH AND PERINATAL OUTCOME
Group Condition IUD Still birth Live born Total Chi sq p
Control Absent 1 1 98 100
Study
Absent 0 1 (50%) 71 (75.5%) 72
11.35 0.003Present 4 1 (50%) 23 (24.5%) 28
Total 4 2 94 100
Group APGAR1 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Absent 93 4 3 100
Study
Absent 48 20 (54.1%) 4 (26.7%) 72
39.86 0.0001Present 0 17 (45.9%) 11 (73.3%) 28
Total 48 37 15 100
Group NNC Death Without comp With comp Total Chi sq p
control absent 1 98 1 100
study
absent 1 (11.1%) 68 (93.2%) 3 (16.7%) 72
60.08 0.0001present 8 (88.9%) 5 (6.8%) 15 (83.3%) 28
Total 9 73 18 100
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TABLE 8
UMBILICAL ARTERY PATTERN
UM pattern Control Study
Normal 100 45
Abnormal 55
FIG 5: UMBILICAL ARTERY PATTERN DISTRIBUTION
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TABLE 9
UMBILICAL ARTERY PATTERN AND PERINATAL OUTCOME
Group APGAR1 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Normal 93 4 3 100
Study
Normal 43 (89.6%) 2 (5.4%) 0 45
74.26 0.0001Abnormal 5 (10.4%) 35 (94.6%) 15 55
Total 48 37 15 100
Group NNC Death Without comp With comp Total Chi sq p
Control Normal 1 98 1 100
Study
Normal 0 45 (61.6%) 0 45
30.26 0.0001Abnormal 9 28 (38.4%) 18 55
Total 9 73 18 100
19
TABLE 10
UMBILICAL ARTERY HIGH RESISTANCE
UM_HR Control Study
Absent 100 44
Present 56
TABLE 11
UMBILICAL ARTERY HIGH RESISTANCE AND PERINATAL
OUTCOME
Group APGAR1 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Absent 93 4 3 100
Study
Absent 43 (89.6%) 1 (2.7%) 0 44
77.87 0.0001Present 5 (10.4%) 36 (97.3%) 15 56
Total 48 37 15 100
Group NNC Death Without comp With comp Total Chi sq p
Control Absent 1 98 1 100
Study
Absent 0 44 (60.3%) 0 44
29.06 0.0001Present 9 29 (39.7%) 18 56
Total 9 73 18 100
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TABLE 12
UMBILICAL ARTERY AEDF
UM_AEDF
Control Study
Frequency Percent Frequency Percent
Absent 100 100 46 46
Present 54 54
Total 100 100
TABLE 13
UMBILICAL ARTERY AEDF AND ITS PERINATAL OUTCOME
Group APGAR1 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Absent 93 4 3 100
Study
Absent 44 (91.7%) 2 (5.4%) 0 46
77.62 0.0001Present 4 (8.3%) 35 (94.6%) 15 54
Total 48 37 15 100
Group NNC Death Without comp With comp Total Chi sq p
Control Absent 1 98 1 100
Study
Absent 0 46 (63%) 0 46
31.5 0.0001Present 9 27 937%) 18 54
Total 9 73 18 100
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TABLE 14
UMBILICAL ARTERY REDF
UM_REDF
Control Study
Frequency Percent Frequency Percent
Absent 100 100 71 71
Present 29 29
Total 100 100
TABLE 15
UMBILICAL ARTERY REDF AND DELIVERY OUTCOME
Group Condition IUD Still birth Live born Total Chi sq p
Control Absent 1 1 98 100
Study
Absent 0 0 71 (75.5%) 71
15.63 0.0001Present 4 2 23 (24.5%) 29
Total 4 2 94 100
22
TABLE 16
UMBILICAL ARTERY REDF AND PERINATAL OUTCOME
Group APGAR1 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Absent 93 4 3 100
Study
Absent 47 (97.9%) 24 (64.9%) 0 71
54.29 0.0001Present 1 (2.1%) 13 (35.1%) 15 29
Total 48 37 15 100
Group NNC Death Without comp With comp Total Chi sq p
Control Absent 1 98 1 100
Study
Absent 0 71 (97.3%) 0 71
9.5 0.01Present 9 2 (2.7%) 18 29
Total 9 73 18 100
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TABLE 17
MCA PATTERN
MCA pattern Control Study
Normal 100 83
abnormal 17
FIG 6: MCA PATTERN DISTRIBUTION
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TABLE 18
MCA PATTERN AND DELIVERY OUTCOME
Group Condition IUD Still birth Live born Total Chi sq p
Control Normal 1 1 98 100
Study
Normal 0 0 83 (88.3%) 83
31.16 0.0001Abnormal 4 2 11 (11.7%) 17
Total 4 2 94 100
TABLE 19
MCA PATTERN AND PERINATAL OUTCOME
Group APGAR1 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Normal 93 4 3 100
Study
Normal 47 (97.9%) 33 (89.2%) 3 (20%) 83
50.76 0.0001Abnormal 1 (2.1%) 4 (10.8%) 12 (80%) 17
Total 48 37 15 100
Group NNC Death Without comp With comp Total Chi sq p
Control Normal 1 98 1 100
Study
Normal 0 72(98.6%) 11 (61.1%) 83
62.69 0.0001Abnormal 9 1 (1.4%) 7 (38.9%) 17
Total 9 73 18 100
25
TABLE 20
MCA IDF
IDF Control Study
Absent 100 83
Present 17
FIG 7: MCA IDF DISTRIBUTION
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TABLE 21
MCA IDF AND DELIVERY OUTCOME
Group Condition IUD Still birth Live born Total Chi sq p
Control Absent 1 1 98 100
Study
Absent 0 0 83 (88.3%) 83
31.16 0.0001Present 4 2 11 (11.7%) 17
Total 4 2 94 100
TABLE 22
MCA IDF AND PERINATAL OUTCOME
Group APGAR1 >7/10 5/10-6/10 <4/10 Total Chi sq p
Control Absent 93 4 3 100
Study
Absent 47 (97.9%) 33 (89.2%) 3 (20%) 83
50.77 0.0001Present 1 (2.1%) 4 (10.8%) 12 (80%) 17
Total 48 37 15 100
Group NNC Death Without comp With comp Total Chi sq p
Control Absent 1 98 1 100
Study
Absent 0 72 (98.6%) 11 (61.1%) 83
62.69 0.0001Present 9 1 (1.4%) 7 (38.9%) 17
Total 9 73 18 100
27
TABLE 23
UTERINE ARTERY HIGH RESISTANCE AND DELIVERY
Group Delivery Vaginal Instrumental LSCS Total Chi sq p
Control Absent 78 5 17 100
Study
Absent 52 (92.9%) 1 20 (46.5%) 73
26.88 0.0001Present 4 (7.1%) 0 23 (53.5%) 27
Total 56 1 43 100
TABLE 24
UMBILICAL ARTERY PATTERN AND DELIVERY
Group Delivery Vaginal Instrumental LSCS Total Chi sq p
Control Normal 78 5 17 100
Study
Normal 43 (76.8%) 1 1 (2.3%) 45
55.72 0.0001Abnormal 13 (23.2%) 0 42 (97.7%) 55
Total 56 1 43 100
28
TABLE 25
UMBILICAL ARTERY HIGH RESISITANCE AND DELIVERY
Group Delivery Vaginal Instrumental LSCS Total Chi sq p
Control Absent 78 5 17 100
Study
Absent 42 (75%) 1 1 (2.3%) 44
53.4 0.0001Present 14 (25%) 0 42 (97.7%) 56
Total 56 1 43 100
TABLE 26
UMBILICAL ARTERY AEDF AND DELIVERY
Group Delivery Vaginal Instrumental LSCS Total Chi sq p
Control Absent 78 5 17 100
Study
Absent 44 (78.6%) 1 1 (2.3%) 46
58.11 0.0001Present 12 (21.4%) 0 42 (97.7%) 54
Total 56 1 43 100
29
TABLE 27
UMBILICAL ARTERY REDF AND DELIVERY
Group Delivery Vaginal Instrumental LSCS Total Chi sq p
Control Absent 78 5 17 100
Study
Absent 52 (92.9%) 1 18 (41.9%) 71
31.13 0.0001Present 4 (7.1%) 0 25 (58.1%) 29
Total 56 1 43 100
TABLE 28
MCA PATTERN AND DELIVERY
Group Delivery Vaginal Instrumental LSCS Total Chi sq p
Control Normal 78 5 17 100
Study
Normal 51 (91.1%) 1 31 83
6.41 0.04Abnormal 5 (8.9%) 0 12 17
Total 56 1 43 100
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DISCUSSION
When the pre eclampsia sets in very early during pregnancy , close
monitoring of the patient is necessary. The utero placental  circulation is also
safeguarded by controlling the high blood pressure.
The identification of the women at risk of pre eclampsia is essential in the
antenatal period. The prompt treatment at the initial stage may prevent  severe
morbidities for both mother and fetus.
HISTORICAL ASPECTS
Historically, this disorder was reported nearly 2000 years back when Celus
reported as seizures in pregnant women that occur after delivery.
This abnormality was given the name “ECLAMPSIA” in greek which means
lightening , because of its rapid and unexpected appearance.
In the middle of 1800s, urinary examination  of proteins in pregnant women
with  eclampsia revealed that severe proteinuria may antedate  seizure.
In the later part of 1800s, when it become possible to measure blood pressure
with sphygmomanometer, it is apparent that, high blood pressure  antedate the
seizures.
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HYPERTENSIVE DISORDERS IN PREGNANCY
Hypertensive disorder complicating pregnancy are common and form one of
the deadly triad, along with haemorrhage and infection, that continues to be
responsible for increased maternal morbidity and mortality related to pregnancy.
CLASSIFICATION
According to working group of National Institute of Health working group
on High Blood Pressure in pregnancy(2000) ,  hypertensive disorders complicating
pregnancy are classified into 4 types
Gestational hypertension
Preeclampsia - eclampsia
Pre-eclampsia superimposed on chronic hypertension
Chronic hypertension
The major changes proposed in this classification based on the current
evidence were eliminating edema and the change in blood pressure ( 30 mm rise in
systolic and 15 mm in diastolic)  as diagnostic criteria , and the adoption of
korotkoff phase V to determine diastolic pressure. The term pregnancy induced
hypertension was abandoned.
GESTATIONAL HYPERTENSION
It is defined as sustained  systolic blood pressure of ≥140 mm hg or diastolic
blood pressure ≥ 90 mm hg first time in pregnancy after 20 weeks of gestation. This
32
is best confirmed when evidence is present on two occasions at least 6 hours apart
but within 7days.
Not accompanied by proteinuria. Blood pressure returns back to normal
within 12 weeks of postpartum period.
PRE- ECLAMPSIA
It is defined as rise in blood pressure with proteinuria, edema may be
present.
Proteinuria ≥300 mg/24 hrs urine collection or 30 mg /dl. That is equivalent
to 1+ in dipstick tests in random urine samples
It is classified in to two types,
Non severe pre eclampsia
Severe pre eclampsia
Pre eclampsia is considered as severe if any of the following is present
Systolic blood pressure ≥ 160 mm hg or diastolic blood pressure ≥
110 mm hg.
Proteinuria more than 5g/ 24 hrs urine collection samples. Or 3+ more
on random samples.
Oliguria (less than 500ml/24hours)
Thrombocytopenia (platelets <1 lakh /µL )
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Symptoms like persistent headache, visual disturbances, upper
abdominal pain.
Convulsion
Microangiopathic hemolysis- increased lactate dehydrogenase
Elevated serum creatinine
Elevated serum transaminase
Pulmonary edema
Fetal growth restriction.
ECLAMPSIA
In a women with pre eclampsia, a convulsion that cannot be attributed to
another cause is termed as Eclampsia. The seizures are generalised and may appear
before, during, or after labour.
PRE ECLAMPSIA SUPERIMPOSED ON CHRONIC HYPERTENSION
New onset of  proteinuria in women with  hypertension alone in early
pregnancy. Women with hypertension and proteinuria  before 20 weeks  of
gestation exhibiting sudden increase in blood pressure, sudden increase in
proteinuria, thrombocytopenia and increased liver enzymes.
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CHRONIC HYPERTENSION
Hypertension present before pregnancy or first diagnosed before 20 weeks of
gestation. Additionally, when gestational hypertension does not resolve after
delivery, the condition is reclassified as chronic hypertension.
INCIDENCE AND RISK FACTORS
Incidences varies from 3 – 10 % in nulliparous women. In developing
countries they rank second only to anaemia. A number of social, genetic, medical
and obstetric conditions predispose to an increased risk of pre eclampsia.
RISK FACTORS
Extremes of age. ( higher in teenage )
Nulliparity
Obesity  BMI> 35 kg/m2
Multifetal gestation
GHT – 13 versus 16%  in singleton pregnancy
Pre eclampsia – 13 versus 5 % in singleton pregnancy.
Hydatidiform  mole
Hydrops fetalis
Chronic hypertension.
Maternal diabetes.
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Renal disorders.
Antiphospholipid syndrome
Systemic lupus erythematosus
Auto immune disorders
h/o smoking
abnormal uterine artery Doppler at 18 to 24 weeks.
Family h/o pre eclampsia ( genetic)
Age :
Pre eclampsia commonly occurs at both extremes of reproductive age, but is
greatest in women less than 20 years of age. White and African American women,
15- 17 years of age, were found to have 2.6-2.4 times risk respectively to develop
pre-eclampsia compared to their 25-34 year old counterparts. Women who get
pregnant after more than 10 years since the last pregnancy also have a greater risk.
Genetic factors :
In 1873, Elliot described the familial nature of the disease which was
reviewed by Chesley in the year 1968. Elliot  reported a patient who died of
eclampsia.  Her  mother had a similar end, and four of her sister had eclampsia
which proved fatal in three. There is a presence of increased susceptibility of the
inherited genes from the pre eclamptic mother to the foetuses, which are capable of
triggering pre eclampsia.
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It is a multifactorial polygenic syndrome. Some of the genes responsible for
this syndrome are
MTHFR gene affecting methylene tetra hydro folate reductase
Angiotensinogen gene(AGT)
Factor V(leiden) gene
HLA genes ( various) causing immunological tolerance
NOS3 ( Glu 298Asp) gene affecting endothelial nitric oxide production
CTLA 4  cytotoxic T lymphocyte associated protein
LPL lipoprotein lipase
SERPINE 1 Serine peptidase inhibitor
F2 prothrombin( factor II ) gene
ACE (Angiotensin converting enzyme) gene.
ETIOLOGY :
Inspite of various researches over  years, the exact cause of pre eclampsia
remains unclear. Gestational hypertension disorders  occurs in women those
Are exposed to   chorionic villi for  first time
Are exposed to  super abundance of chorionic villi , as in multiple pregnancy
or molar pregnancy.
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With pre existing condition of endothelial cell activation or inflammation
such as diabetes or renal or cardiovascular disease.
Are genetically predisposed.
According to Sibai (2003),  potential causes include the following
Abnormal  invasion of trophoblast in the uterine vasculature.
Intolerance between  maternal and fetoplacental tissues.( Immunological)
Maternal response to the  cardiovascular  changes of   normal pregnancy.
Dietary deficiencies.
Genetic.
IMMUNOLOGICAL THEORY :
The possibility that immunological as well as  the endocrine and genetic
mechanisms are involved in  genesis of pre eclampsia. The risk of pre-eclampsia is
enhanced in the circumstances where, there is an impairment in the  formation of
antibodies to the sites of antigen on the placenta  or where the number of antigens
produced by the  placenta is more  when compared  to antibody as in multiple
pregnancy.
However some studies found no association of compliment factors c3, c3F
with pre eclampsia.
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GENETIC THEORY :
In the year 1979, Cooper and Liston revealed that the  preeclamsia  depends
upon a single recessive gene, but multifactorial inheritance cannot be excluded.
DIETARY DEFICIENCY :
Some  workers implicated that  calcium  deficiency might be one of the
cause for  pre eclampsia. Studies have reported that dietary supplements of 2gm of
calcium per day after mid pregnancy reduce the incidence of preeclampsia.
ETIOPATHOGENESIS :
As Boyd stated pre eclampsia remains “ die krankheit der theorien” the
disease of theories. More accepted theories  included  abnormal trophoblast
invasion of uterine blood vessels, changes in  vasomotor activity, plasma volume
and coagulation system. Their disturbances had been attributed to the endothelial
cell activation or dysfunction and abnormal placentaion.
VASOSPASM :
The basic pathophysiology of pre eclampsia  is vasospasm. Vasoconstriction
causes resistance to blood flow and leads to the development of arterial
hypertension.
ABSENCE OF SPIRAL ARTERIES REMODELLING :
“The inciting organ for development of pre eclampsia is placenta”
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Uteroplacental vessels undergo two stages
First stage : before 12 weeks post fertilisation upto  interface between the
decidua and myometrium
Second stage : between 12 to 16 weeks. It involves invasion of
intramyometrial segments of spiral arterioles.
Normally  cytotrophoblasts of the developing placenta migrates through
decidua and myometrium and  invade the tunica media of the spiral arteries which
supply blood to  fetus. So these changes leads to  transformation of small muscular
arterioles to a  large low resistence vessels. These changes occur at the end of first
trimester and completed  by 18 - 20 weeks of gestation.
But in  preeclampsia , cytotrophoblasts fails to penetrate myometrial segment
and so, the spiral arteries remains narrow and results in  hypoperfusion of  placenta
which is the important component in  preeclampsia pathogenesis. This placental
ischemia causes maternal endothelial dysfunction.
In  1980, Dewolf and coworkers examined  arterioles from the placental
implantation site using electron microscopy and they found that in ealy stages there
is damage of endothelial cells, accumulation of lipids in the myointimal cells
resulting  in narrow lumen.
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FIG 8: PATHOPHYSIOLOGY OF PRE ECLAMPSIA
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IMMUNOLOGICAL INTOLERANCE
There was  evidence to support that pre eclampsia is immune mediated.
Immunologists  explained that this condition where there is abnormality of the
immune protective mechanism are shown to prevent the mother from rejecting
fetuses. To support  this concept ,  pre eclampsia is uncommon in patients who are
immunosuppressed. From the early second trimester, women who are at risk of
developing pre eclampsia had a significantly low  number of T helper  cells
compared with normotensive pregnant women. Adenosine mediated Th1/Th2
imbalance, seem to be high in pre- eclamptic women in comparison to the normal
pregnant women.
Placental changes in pre eclampsia have shown some similarity which is
found in rejected kidney after transplantation.
“ The evidence supporting  this theory is that  there may be a loss of maternal
tolerance to  paternally derived placental and fetal antigen”.
Placenta has both paternal and maternal halotypes and genetic determinants.
Compared to  normal pregnant patients there is decreased level of messenger RNA
for HLA-G  in women with pre eclampsia.
Cytokines particularly the  tissue necrosis factor(TNF α), interleukin 2 (IL2)
and interleukin 6(IL6) are the mediators of immune maladaptation in pre eclampsia.
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ENDOTHELIAL CELL ACTIVATION
If  endothelium is intact, it will have anticoagulant property   by releasing the
nitric oxide and  it blunts  the vascular smooth muscle response to agonist. So
endothelial cell damage release pro coagulants and there is decreased nitric oxide
production and there is increased sensitivity to the pressors.
FIG 9: ENDOTHELIAL CELL ACTIVATION
PROSTAGLANDINS
Compared with normal pregnancy, production of endothelial prostacyclin
(PGI2) is reduced in pre-eclampsia. Also there is an increased production of
thromboxane A2 by platelets, so the prostacyclin : thromboxane ratio is decreased.
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This leads to an  increased response to vasopressor angiotensin II and finally
leading to vasoconstriction.
NITRIC OXIDE
Nitric oxide, a potent vasodilator is produced by endothelial cells from L-
Arginine. Reduced  nitric-oxide synthesis in pre eclampsia increases mean arterial
pressure  and increases the sensitivity to  vasopressor agents. The effect of nitric
oxide production in pre eclampsia remains unclear.
OXIDATIVE STRESS
Pre eclampsia is due to  activated leucocytes in the maternal circulation.
Decidua contains a large group of cells which on activation releases noxious agents
like the tumor necrosis factor- α, and leukotrienes  which are responsible for the
oxidative stress.
Prostaglandins
imbalance
Coagulation
cascade
activation
Increased capillary
permeability
(edema &
proteinuria)
Release of
macrophages (lipid
laden) and foam
cells
Endothelial
damage
Oxidative stress
Oxygen free radicals
Reduced  Nitric
oxide
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ENDOTHELINS
A potent vasoconstrictor  produced by human endothelium. Endothelin levels
are increased in pre eclamptic women compared with normal women. Some  report
shows that the magnesium sulphate decreases the endothelin I concentration.
ANGIOGENIC AND ANTI ANGIOGENIC PROTEINS
Balanced production of  angiogenic and anti angiogenic factors are
responsible for  normal  development of placenta.
In  pre eclampsia, there is increased production of antiangiogenic factors
resulting in endothelial dysfunction. New  Researches  currently  use
antiangiogenic proteins in  prediction and diagnosis of pre eclampsia.
Two antiangiogenic proteins that increased in  maternal circulation are :
Soluble endoglin:
It is  65 kDa molecule derived from placenta  which inhibits TGF-β isotopes
from binding with endothelial receptors, which decreases the nitric oxide release
from  endothelium.
Soluble FMS like tyrosine kinase – 1 :
It decreases the placental endothelial growth factor and vascular endothelial
growth factor,  leading  to  endothelial dysfunction.
Both  of these antiangiogenic factors begins to rise in  maternal serum before
pre eclampsia develops .
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Increased  level of antiangiogenic factors in the  second trimester is
associated with increased risk for  pre eclampsia  which  is produced by
trophoblastic tissue , which enters in to the maternal circulation causing  angiogenic
imbalance.
PATHOPHYSIOLOGY OF  PRE ECLAMPSIA
Arachidonic Acid (Essential Fatty Acid)
PG I2 PGE2 TXA2
NORMAL
Vasodilatation
Platelet aggregation
Uteroplacental  blood flow
PRE ECLAMPSIA
Vasoconstriction
Platelet aggregation
Uteroplacental blood flow
Vasodilatation Vasoconstriction
Nitric oxide Vascular refractoriness Vascular responsiveness Endothelin I
to vasopressors                    to vasopressors
Angiotensinogen Renin
(kidney)
Angiotensin I
Angiotensin II
46
RETENTION OF SODIUM
There is an increased plasma volume , glomerular filtration rate and renal
blood flow in normal pregnancy, but in pre eclamptic women, there is decreasein
plasma volume, renal blood flow and glomerular filtration rate resulting in
retention of sodium  which increases the sensitivity of vasopressors in pre
eclampsia.
All  signs and symptoms of pre eclampsia are well explained by response to
generalised endothelial dysfunction.
Increased vascular permeability leads to  development of proteinuria and
edema.
Disturbed vascular tone of the endothelial cells leads to  hypertension.
Expression of  the pro-coagulants leads to coagulaopathy.
Endothelial dysfunction in the vasculatures  of brain, liver, kidney and
placenta causes headache, seizures, epigastric pain, visual disturbances and fetal
growth restriction
In severe pre eclampsia , angiotensin II causes vasoconstriction which leads
to local hypoxia  and causes haemorrhage & necrosis causing end organ damage.
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FIG 10: OVERVIEW OF PATHOPHYSIOLOGY
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PATHOLOGICAL CHANGES
Pre eclampsia occurs in two stage.
Asymptomatic stage
Abnormal placental development during first trimester.
Placental insufficiency
Symptomatic stage
Hypertension,  proteinuria.
CARDIO VASCULAR SYSTEM
Blood pressure = cardiac output  X  total peripheral resistance.
Normally cardiac output  increases during pregnancy, but it rises further in
pre eclampsia. Total peripheral resistance decreases during normal pregnancy
whereas here it increases. This is the main cause of  high blood pressure.
In pre eclampsia incidence  of pulmonary edema is increased.
HEMATOLOGICAL SYSTEM
Normally, total blood volume increases because of  the expansion of plasma
leading to physiological anemia  ( hemo dilution )of pregnancy. This expansion in
blood volume is reduced in gestational hypertension. Decreased regional perfusion
in gestational hypertension resulting in  hemoconcentration.
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Contraction  of  intravascular space is associated with  vasospasm and
subsequent hemoconcentration. Haematocrit increases with increased severity of
pre eclampsia. An attempt  to expand the intravascular space by fluid therapy may
increase pulmonary wedge pressure  resulting  in pulmonary edema because of
capillary leak.
Main pathophysiology of pre eclampsia is  vasospasm , which results in
endothelial injury. This endothelial injury is responsible for  microangiopathic
hemolysis resulting in fragmentation of red blood cells, thrombocytopenia and
anemia.
There is a low level of antithrombin III  and high levels of fibronectin
helping in  diagnosis of pre eclampsia and it differentiates from  chronic
hypertension.
BLOOD AND COAGULATION
Among the haematological abnormality, thrombocytopenia is  characteristic
of pre eclampsia which may be life threatening.
Activation of  platelets will lead to the endothelial dysfunction. Coagulation
system is activated by  tissue factor  present in endothelium. This results in
widespread  disseminated intravascular coagulation(DIC).
THROMBOCYTOPENIA
Thrombocytopenia was described by Stancke in  1922, in  patients with pre
eclampsia. The platelet count is routinely done in all pre eclampsia patients.
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Intensity of thrombocytopenia depends on the duration and severity of pre
eclampsia. The platelet count < 1 lakh/µL indicates the severity. The platelet count
decreases on the first day after delivery, then reaches the normal value  in 4 to 5
days.
HELLP SYNDROME
It was first coined by Weinstein. It comprises of
Hemolysis
Elevated Liver enzymes
Low Platelet count
COAGULATION
Following are some of the abnormalities  in pre eclampsia
Decreased levels of antithrombin III
Decreased plasma fibrinogen level
Decreased levels of Protein C and S
Increased levels of fibrin degradation products
Increased levels of fibrino peptides A & B
ENDOCRINE SYSTEM
Angiotensin II , catecholamine and vasopressin play an important role in
high blood pressure and increased  vascular resistance. Vascular sensitivity to
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angiotensin II occurs 8 to 12 weeks prior to the onset of clinical symptoms pre
eclampsia.
Indomethacin and aspirin are prostaglandin inhibitors which  decreases the
vascular sensitivity to angiotensin II.
RENAL SYSTEM
There is a reduction in  renal perfusion and glomerular filtration rate due to
increased resistance of renal afferent arterioles. Glomerular endotheliosis occurs
blocking  the filtration barrier. Sodium concentration in urine is increased.
Fractional excretion of sodium urine osmolality and urine plasma creatinine ratio is
an indication of pre renal involvement.
Serum uric acid concentration is elevated in pre eclampsia  due to  reduction
in glomerular filtration rate and increased tubular reabsorption. In pre eclampsia
there is decreased urinary excretion of calcium occurs.
RENIN – ANGIOTENSIN – ALDOSTERONE SYSTEM
It is responsible for the maintainence of  norrmal blood pressure, sodium and
blood volume status. Normally, plasma renin concentration and its activity,
angiotensinII and aldosterone levels are increased and reduced refractoriness to
angiotensin II effects.
But in pre eclampsia, there is a loss of refactoriness to angiotensin II effect
which is demonstrated as early as 18 to 22 weeks of gestation .
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LIVER
Commonly found pathological lesion in liver is periportal haemorrhagic
necrosis. It manifest as  epigastric pain and tenderness associated with elevation of
liver enzymes alanine transferase and aspartate transferase.
Elevation  of liver enzymes without symptoms are considered as markers of
severe pre eclampsia. They ususally  become normal within 3 days of delivery.
Sometimes preeclampsia is confused with acute fatty liver of pregnancy, because it
is also associated with hypertension, thrombocytopenia and elevated liver enzymes.
Brain
Brain involvement in pre eclampsia was first described from the autopsy
specimens. But CT, MRI and Doppler studies gives much more important
information of cerebrovascular system. Multiple petechial haemorrhages or larger
haemorrhage in cortex, pons or midbrain. Intracerebral haemorrhage is seen in 60 %
of eclampsia and  is fatal in 30% of eclampsia..
Haemorrhage in basal ganglia, sub cortical edema, multiple non
haemorrhagic areas of softening are also seen. Microscopic appearance of vascular
lesions includes perivascular microinfarcts,  haemorrhages and fibrinoid necrosis of
arteriolar walls.
There are two theories to explain the cerebral involvement in women with
eclampsia.
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The first theory explains that  vasospasm in  cerebrovascular system based
on angiographic images of diffuse or focal segmental narrowing of vessels.
Diminished cerebral blood  flow results in ischemia, infarction and edema.
The second theory is  that if there is a sudden elevation of  blood pressure it
may exceed the normal auto regulatory capacity.
There is a disruption in  end capillary pressure  resulting in vasogenic edema
because of increased hydrostatic pressure, extravastation of plasma and red cells
through tight junctional opening.
VISUAL CHANGES
Diplopia , blurring of vision and scotoma occurs. Blindness is less common
and it is reversible. Blindness  from retinal lesion is caused either by serous  retinal
detachment or by retinal infarction which is termed Purtcsher retinopathy.
Occasionally it accompanies with cortical edema. Eclampsia induced visual
disturbances is an reversible condition.
UTEROPLACENTAL PERFUSION
Vasospasm  results in decreased uteroplacental perfusion which is important
in the pathogenesis of pre eclampsia. Previously studies were done to access the
uteroplacental perfusion by peak systolic : diastolic  velocity  ratios from uterine
and umblical arteries in women with pre eclampsia.
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COMPLICATIONS
Maternal :
CENTRAL NERVOUS SYSTEM
Eclampsia
Cerebrovascular accident
Intracerebral haemorrhage or occasionally intracranial aneurysmal rupture.
Retinal detachment
Cortical blindness
RESPIRATORY SYSTEM
Pulmonary edema with or without left ventricular failure. It develops in 2.9%
of pregnancies complicated by pre eclampsia.
Acute respiratory distress syndrome
RENAL SYSTEM
Renal cortical necrosis
Renal tubular necrosis
Renal failure - characterised by marked reduction in the glomerular filtration
which leads to increased retention of urea, electrolytes and acid base abnormalities.
55
LIVER
HELLP syndrome
Hepatic rupture
It is one of the most severe consequences of pre eclampsia. It occurs more
commonly in the elderly women in their first pregnancy.
Endothelial dysfunction + intravascular fibrin deposits
Hepatic sinusoidal obstruction
Increase in intrahepatic vascular congestion and pressure and
Distortion of Glisson’s capsule
Development of subcapsular hepatic hematoma and liver rupture
Fatty liver
HAEMATOLOGICAL - Disseminated intravascular coagulation (DIC)
Characterised by  increase in fibrinolysis and fibrin formation  leading to
consumption of clotting factors, presenting as bleeding diathesis. Severe pre
eclampsia is the most common cause of  disseminated intravascular coagulation.
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PLACENTA abruption placenta
Fetal :
“Preeclampsia is considered to be the maternal disorder in which  fetus is an
incidental participant, but from the fetus point of view , it is the fetal disorder and
mother  is an incidental participant.”
In normal singletons, pre eclampsia is the major cause of intra uterine growth
restriction. It indicates  early onset severe disease. Because of diminished utero-
placental blood flow, there is anoxia  leading to liberation of thromboplastic
substances from  placenta which initiates intravascular coagulation.
There  is
Increased secretion of chorionic gonadotropin
Increased secretion of steroid hormones
Deterioration of  transport mechanism of vital aminoacids .
All of the above factors contributes to fetal hypoxia and IUGR of fetus.
Intra uterine fetal growth restriction(IUGR)
Intrauterine death (IUD)
Prematurity  more likely to be iatrogenic in pre eclampsia
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PREDICTION AND PREVENTION OF PRE ECLAMPSIA
Many attempts were made to find the early markers of impaired placenta
perfusion, endothelial cell activation and dysfunction and faulty placentation. There
is no valid screening test to predict pre eclampsia .
In  year 2009, Conde-Agudelo and  associates  provided  the review for the
tests.
Placental perfusion/ vascular resistance :
Roll over test
Isometric handgrip or cold pressor test
Angiotensin II infusion
Mid trimester mean arterial pressure
Platelet angiotensin II binding
Renin
24- hour ambulatory blood pressure monitoring
Uterine artery  doppler
Fetal Doppler velocimetry.
Fetal placental unit endocrine dysfunction
Human chorionic gonadotropin(hCG)
Alpha feto protein (AFP)
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Estriol
Pregnancy associated protein A (PAAP A)
Inhibin A
Activin A
Placental protein 13
Corticotropin releasing hormone
Renal dysfunction
Serum uric acid
Microalbuminuria
Urinary calcium or kallikrein
Microtransferrinuria
N-acetyl- β-glucosaminidase.
Endothelial dysfunction/ oxidant stress
Platelet count and activation
Fibronectin
Endothelial adhesion molecule
Prostaglandins  &Thromboxane
c-reactive protein & cytokines
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endothelins&neurokinins B
VEGF, PlGF,PAI.
Leptin& p-selectin
Endoglin
Miscellaneous
Anti thrombin III
β 2 microglobulin
Atrial Natriuretic Peptides
Uterine artery Doppler
Non pregnant women
Reduced diastolic flow and notching of the uterine artery
Normal pregnancy
Due to the trophoblastic invasion, the notch disappears and flow increases.
“IF THERE IS PERSISTENCE OF A DIASTOLIC NOTCH IN THE
UTERINE ARTERY OR INCREASED RESISTANCE AT 20 -22 WEEKS- it
indicates second stage of trophoblastic invasion has not occurred”
This helps in the prediction of pre eclampsia and IUGR. In general, the
uterine Doppler test is  best among all the above test as there is no other test that are
truly predictive. The latest combination method in first trimester include the
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prediction of pre eclampsia is uterine artery Doppler along with pregnancy
associated plasma protein(PAPP- A) and placental protein 13.
METHODS OF PREVENTION
Low salt diet
Salt restriction was  earliest research efforts to prevent pre eclampsia(De
snoo 1937). In 1998, knuist and collegue reported that salt restricted diet was not
effective in prevention of pre eclampsia.
Calcium supplementation
In the 1980’s(Belizan and vilar ) studies were shown that patients with intake
of low dietary calcium had increased  the risk of pre-eclampsia .
Various studies (Levine and collegues ) shows  that unless the women has
calcium deficiency, calcium supplementation has no effects on reducing pre
eclampsia .
Fish oil supplementation
Eicosapentanoicacid  and alpha linoleic acid are the most common dietary
source of fish oil. It might  prevent inflammatory mediated atherogenesis. But
randomised trials (Makrides 2006, olafsdottir 2006, olsen 2000, and their
collegues)shown that there is no such benefits.
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Antioxidants
Vitamin C & vitamin E are  naturally occurring anti oxidants which are
reduced   in pre eclampsia.( Raijmakers and associates 2004).
Thus supplementation of anti oxidants improves the oxidative property of
women who are at  risk of pre eclampsia. But  (Poston 2006, Rumbold 2006)
studies revealed that   eclampsia has not reduced by the use of antioxidants.
Antithrombotic agents
Low dose aspirin
Wallenburg and associates 1986 studied that daily oral dose of  50 to 150 mg
aspirin inhibits thromboxane A2 synthesis. Paris collaborative group performed a
meta analysis which showed that the relative risk of pre eclampsia was reduced by
10%.
Low dose aspirin + heparin
High incidence of thrombotic lesion in the  placenta was found in  severe pre
eclampsia. In the year 2006, sergis and associates analysed the effect of prophylaxis
with low dose aspirin and  low molecular heparin with history of early onset pre
eclampsia and low birth weight babies. They reported that there is a better
pregnancy outcome in patients with low dose aspirin plus low molecular heparin
than those with low dose aspirin alone.
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Physical principles of Doppler Ultrasonography:
Doppler effect:
“Observed changes in the  frequency of the energy wave transmission when
relative motion occurs betweenthe  source of wave transmission and  observer”.
This change in  frequency is called  Doppler frequency shift/Doppler shift.
fd = ft-fr where fd - Doppler shift frequency
ft - transmittedfrequency
fr - receivedfrequency
Wave length decreases and the frequency increases, when the observer and
the source move close to each other. Also, wavelength increases and frequency
decreases when the observer and the source move away from each other. All forms
of wave propagation applies this principle. The frequency shift  is proportional to
speed of movement. This principle is used in the Doppler effect.”.
FIG 11: DOPPLER EFFECT
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Doppler ultrasound:
“Even  when an ultrasound beam encounters the blood flow, the principle of
Doppler effect is seen. The moving targets within the  blood circulation are millions
of erythrocytes. This moving sources forms the basis of  Doppler equation.
fd = 2 ft   V/C,  fd - Doppler frequency shift,
ft - frequency of incident beam ( transducersfrequency)
V - velocity of scatterer in a given direction
C - propogation speed of sound in  medium
When  direction of  incident beam is at an angle to  direction of blood flow, the v in
above equation is substituted by  component of  velocity in  direction of the flow
(obtained by  cos Ѳ)
fd = 2 ft cos V/cosѲ
To find velocity,
V = fd c/2ft cos Ѳ
The  equation  above is the basis in clinical application of  Doppler principle”.
High pass and low pass filtering:
Two kinds of filters in use are
1. High pass filter
2. Low pass filter
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High pass filter system  eliminates   the external  low frequency component
of Doppler signal, that arise  from  vessel wall. This should be used with caution as
high setting eliminates end diastolic frequency shift from umbilical or
uteroplacental circulation.
Technical considerations:
Four types of devices used to obtain Doppler signals are
Continuous wave Doppler:
Is relatively inexpensive machine which has two crystals. Of which one send
high frequency and other receives  signals continuously. It has the advantage to
record high frequencies with low power output. But  it is non selective and
recognise all the signals in its way. The disadvantage is that it  does not allow the
visualisation of blood vessels of interest. It is  useful to detect heart  movements or
even umbilical artery pulsations.
Pulsed Doppler:
By contrast, pulsed Doppler ultrasound is used to assess the flow velocity
patterns within arteries and veins that are simultaneously visualised by gray scale
ultrasound. Pulsed Doppler gate size , pulsed repetition frequency(PRF), angle of
insonation and   the gray scale imaging  can be adjusted to obtain pure waveforms
of high quality.
In general, blood flow velocities in the placental and fetal circulations ranges
between  10 to 80 cm/sec. Pulsed Doppler is thus particularly helpful in obtaining
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reliable uterine artery Doppler wave forms and is essential in assessing the various
parts of the fetal circulation.
Colour flow Doppler:
Colour flow Doppler is an extension of the pulsed Doppler in that colour
signal is assigned to  direction of flow, by convention, red flow towards  probe and
blue flows away from it. Colour flow Doppler, therefore, detects the blood flow
velocity in the same plane as the ultrasound probe.
Low angles of insonation are required in order that flow may be visulaised in
various vessels. Flow is best observed at the appropriate PRF settings. Otherwise no
flow may be detected or a multitude of low flow vessels will obscure the vessels of
interest.
Power Doppler:
Recent technical development that detects the  blood flow velocity
independant of angle of insonation. This method of imaging is particularly useful in
assessing the areas of  high blood flow velocity and delineating the  vascular from
non vascular areas.
Wave form analysis:
Quantitative analysis:
The Doppler output results in  flow velocity wave form (FVW) representing
the velocity envelope through  cardiac cycle. There are three common methods of
describing peak blood flow velocity wave forms.
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Systolic / Diastolic (S/D) ratio : Peak  systolic velocity
End diastolic velocity
Pulsatility Index (PI) : Peak systolic- End diastolic velocity
Mean velocity
= A-B/M
Resistance Index (RI) : Peak systolic- End Diastolic Velocity
Peak systolic velocity
= A-B/A
A = Peak systolic velocity
B = End diastolic velocity
C = Early diastolic velocity
M = Mean velocity
S/D ratio gives a simple evaluation of the blood flow during diastole and
provides estimation of the  down stream resistance.
Pulsatility index is considered as the mean velocity  diameter (ie) the whole
flow is given consideration, not just the diastolic flow and hence can be used to
analyse the data from various vessels without encountering the excessive variation
that can be caused by the  duration by small numbers as with other indices.
The pourcelot index or RI is useful when the diastolic flow is absent or
reversed and when S/D cannot be calculated. It helps in comparing any waveform
irrespective of its diastolic flow.
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Qualitative Analysis :
Qualitative or descriptive methods may be used to describe the  wave forms
in uterine, umbilical or middle cerebral artery circulation.
An abnormal uterine artery waveform may be described either by the
presence or absence of an early diastolic notch or by the PI.
Umbilical and middle cerebral artery Doppler waveforms may be described
as normal with reduced diastolic flow, absent end diastolic flow (EDF) or reversed
EDF.
Uterine Artery :
In  first trimester  of pregnancy, trophoblast invade the uterine vessel and
result in dilated spiral arteries, which increases  uterine perfusion from 10 fold to 12
fold.
Uterine arterial blood flow in a non pregnant women is 50 ml/min and
increases to over 700ml/min in  third trimester of pregnancy and thus the diastolic
component of the uterine artery Doppler is transformed during normal pregnancy
from one of low peak flow velocity and   early diastolic notch to one of the  high
flow velocity and absence of early diastolic notch by 18-22 weeks.
Uterine artery waveform by the mid –second trimester is therefore
characterised by the high end diastolic velocity with continuous forward blood flow
throughout the diastole. In late gestation, the end diastolic flow typically raises.
Indices that quantify the above   waveforms include Pulsatality Index, Resistance
Index and notching of  uterine arteries.
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FIG 12: UTERINE ARTERY EARLY DIASTOLIC NOTCH
FIG 13: NORMAL UTERINE ARTERY DOPPLER
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However failure of   normal endovascular trophoblastic invasion of  spiral
arteries resuts in the increased uterine artery vascular resistance and decreased
perfusion of  placenta. With   extreme degree of placental dysfunction, diastolic
blood flow can be absent or reversed.
A recent literature review reported that the abnormal uterine artery
waveforms are better predictor of preeclampsia than of IUGR when performed after
16 weeks of gestation. An abnormal PI and uterine artery notching in the second
trimester best predicted preeclampsia.
Indication for assessing  uterine vessel Doppler USG are
Previous h/o preeclampsia.
Previous  IUGR.
Elevated  maternal serum AFP.
High hcg levels
Because of high negative predictive value, patient will not develop pre
eclampsia if PI is normal in both uterine vessel.  If one vessel is abnormal, patient is
advised to have   frequent ANC visits.
Umbilical Artery:
The Umbilical artery  Doppler denotes the presence / absence of the
resistance of placental bed to blood flow between fetus and placenta. It  strongly co
relates with  the acid-base balance of  fetus. This measurement  is  Umbilical artery
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S/D ratio. The PI has the advantage of producing a numerical value  when diastolic
flow is absent.
UMBILICAL ARTERY NORMAL DOPPLER
FIG 14: NORMAL UMBILICAL ARTERY DOPPLER
FIG 15: UMBILICAL ARTERY AEDF
71
TABLE 29
DOPPLER VALUES OF UMBILICAL VESSEL
GESTATION
(weeks)
HYPERTENSIVE NORMOTENSIVE
S/D RI PI S/D RI PI
32 – 34 4.74 ±
1.78
0.94 ±
0.26
2.0 ±
0.82
2.92 ±
0.06
0.65 ±
0.02
1.1 ±
0.14
35 – 37 3.54 ±
0.97
0.78 ±
0.12
1.27 ±
0.32
2.36 ±
0.09
0.56 ±
0.03
0.77 ±
0.05
38 – 40 3.09 ±
0.76
0.72 ±
0.11
0.99 ±
0.23
2.23 ±
0.13
0.55 ±
0.02
0.74 ±
0.06
FIG 16: UMBILICAL ARTERY REDF
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To obtain more consistent results , the UA S/D ratio should be obtained in
the free loop of cord midway between the placental insertion, the site of less
resistance and  fetal insertion, the site of maximal resistance flow.
During the  normal pregnancy, UA have low resistance demonstrated by the
presence of abundant diastolic flow and reflected in low S/D ratios. During normal
pregnancy there is a slow and continuous decline in the S/D ratio that reaches its
lowest value after 36 weeks gestation.
When the pregnancy is complicated by the increased placental vascular
insufficiency causing FGR, diastolic flow decreases causing  UA S/D ratio to
increase  2SD  or higher above the mean for the gestational age. An increase in UA
S/D ratio even if it is marked does not  indicate   fetal hypoxia. However, with
progression of placental vascular insufficiency the UA waveforms will show ADF
and finally reversed diastolic flow (RDF) which indicate the presence of fetal
hypoxemia and the need to delivery of   fetus.
Randomised clinical trials and meta analysis have demonstrated that the use
of UA Doppler in high risk pregnancies results in  approximately one third decrease
in the perinatal mortality (Alfirevic and Neilson 1995; Divon 1996, Goffinet et al
1997).
Studies have also demonstrated the strong relationship between the results of
UA velocimetry and the presence of fetal academia in blood sample obtained by
cordocentesis ( Vintzileous et al 1991; Yoon etal 1993)
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Middle Cerebral Artery:
When  placental vascular reistance increases above a certain threshold, the
fetus develops a compensatory response, increasing the blood flow to vital organs
such as the heart and  brain and decreasing the blood flow to  mesenteric, renal and
peripheral circulation. The hemodynamic adaptation protects the integrity of the
fetal brain in the face of diminished availability of nutrients and can be assessed by
comparing the UA and MCA Doppler waveforms.
Under the  normal conditions, the UA waveforms are characterised by
abundant diastolic flow corresponding to a minimal reistance to flow in the fetal
placental circulation. The MCA waveforms are completely different and show
minimum or no diastolic flow
In the early stage of placental insufficiency, there is a decrease in Umbilical
artery diastolic flow and increase in S/D ratio, resulting in a compensatory increase
in brain circulation. This in turn results in increased diastolic blood flow and
decreased MCA S/D ratio.
With the  progression of  placental insufficiency, the UA and MCA S/D
ratios become similar and eventually the MiddleCerebralArtery S/D ratio will
become smaller than the UmbilicalArtery S/D ratio. This is called    Brain Sparing
effect or centralisation of the flow.
Centralisation is  signal that the fetus is under appreciable placental
resistance to flow  and inadequately compensating for this problem by improving
the blood flow to the brain.
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The  MCA should be sampled  near the origin from  internal carotid artery.
Reference values for  MCA PI changes throughout the  pregnancy. The lower PI
values in early and late gestation may be caused by  increased metabolic
requirements of the brain during these periods. Several conditions are associated
with an increase or decrease of the MCA PI when compared to the  normal value.
Other Arteries:
Many other arteries like the descending aorta, splenic artery, superior
mesenteric artery, adrenal artery, renal artery, femoral artery, internal and external
iliac arteries have been studied.
Safety of Doppler ultrasound:
Equipments are regulated to be set for the lowest power settings sufficient to
produce adequate images, known as the ALARA ( As Low As Reasonably
Achievable)
ALARA Principle:
The biological effect of high energy ultrasound includes heating and
cavtitaion of tissues, teratogenicity and mutagenticity.
Cavitation :
It is caused by the vacuum following the ultrasound pulsed wave.
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Heating:
It depends on USG intensity,duration of exposure and type of tissue. Neural
tissue is particularly sensitive to hyperthermia.
Potential pitfalls :
Angle of insonation :
Common Doppler indices such as PI , RI and S/D ratio are not influenced by
angle of insonation. However high angles of insonation will reduce the calculated
peak velocity such that the proportion of the total waveforms attributable to
background noise will become greater.
Wide angles of insonation can lead to apparent loss of diastolic frequencies
leading to error in the diagnosis of placental vascular insufficiency.
Heart Rate :
An increase in the fetal heart rate will shorten the time for diastole and
therefore lead to increased diastolic flow velocity.
Conversely, in complete heart block, a long diastolic phase will result in low
diastolic velocities and high PI values.
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SUMMARY
In this prospective study  in a set up of tertiary level care, significance of
Doppler indices abnormality and its perinatal outcome have been evaluated among
preeclamptic patients.
In the study with uterine artery,  27% were found to have abnormal pattern,
27% with uterine artery high resistance and 28% showed uterine artery early
diastolic notch in study group.
With the study of umbilical artery in the study group, 55% were found to
have abnormal pattern, 56% with umbilical artery high resistance , 54% with absent
end diastolic flow and 29% with reversed end diastolic flow.
17% were found to have abnormal middle cerebral artery pattern among the
study group.
Cesarean section rate incidence was higher in the study group (43%)
compared with the control group (17%).
Neonatal mortality accounted to 8% which is similar to Mikovic study et all.
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CONCLUSION
200 Patients were taken for my study. Out of which 100 belong to control
group and 100 were in study group.
In study group there is an increase in the doppler abnormality among all
three major vessels which includes uterine artery, umbilical artery and middle
cerebral artery.
Umbilical artery and middle cerebral artery doppler abnormality are a better
indicator of perinatal outcome.
Those who have abnormal doppler velocimetry, there is an increased
incidence of still birth and IUD when compared to control group.
Similarly  one minute and five minute APGAR rate for those babies are low
when compared to control group. And also the incidence of neonatal complications
after birth is also increased with abnormal dopper velocimetry.
The incidence of caesarean section rate is increased among abnormal
Doppler velocimetry.
Thus Doppler velocimetry is a major support for the conventional
antepartum surveillance especially in pre eclampsia.
Abnormal doppler velocimetry alarms the obstetrician to plan the pregnancy
in a tertiary care centre with a better NICU setup as it warrants effective monitoring
of the patient and expert neonatal care.
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PROFORMA
Name: Husband name:
Age: Case no:
IP no.: Occupation:
Obs code: Date of admission:
LMP : Date of delivery:
EDD: Socio economic status:
Period of gestation:
Chief complaints:
History of presenting illness:
Menstrual history:
Marital history :
Obstetric history:
Past:
Present:
I trimester
II trimester
III trimester
Past history:
H/O similar illness
H/O hypertension
H/O diabetes/epilepsy/ thyroid disorder/ heart disease/ asthma
H/O renal or liver disease/ auto immune disorder
H/O chronic drug intake/ trauma
Family history:
GENERAL EXAMINATION:
Height:                                                       Breast:
Weight: Thyroid:
PR:                                                             Spine:
BP:                                                             Pedal Edema:
SYSTEMIC EXAMINATION:
CVS:
RS:
PA:
Inspection:
Palpation:
Auscultation:
Investigations:
Hb%
Blood grouping typing:
Blood sugar:
Serum urea:
Serum creatinine:
LFT:
Urine albumin:
Urine sugar:
Urine microscopic exam.:
USG OBS:
Singleton:
Viability:
GA:
Placenta:
Presentation:
AFI:
EFW:
Congenital Anomalies:
Doppler flow in Umbilical artery:
S.D. Ratio R.I P.I. Diastolic flow
Right
Left
Doppler flow in Middle cerebral artery:
S.D. Ratio R.I P.I. Diastolic flow
Right
Left
Doppler flow in Uterine artery:
S.D. Ratio R.I P.I. Diastolic flow
Right
Left
Maternal outcome:
Mode of delivery:
Vaginal:
Assisted vaginal:
LSCS:                              Ind:
Intra natal course and complication if any:
Fetal outcome:
Live birth/ Still birth/ IUD:
Term/ Preterm:
Male/ Female:
APGAR :
Weight of the baby:
HC of the baby:
IUGR:
Ponderal index:
Neonatal complication if any:
Placenta:
Colour of the liquor:
MASTER CHART SCALE
1 2 3
AGE ( years) Less than 20 20 - 30 More than 30
PARITY Primi Multi
UTERINE ARTERY
A) Pattern Normal Abnormal
B) High resistance
flow
Absent Present
C) Early diastolic
notch
Absent Present
UMBILICAL ARTERY
A) Pattern Normal Abnormal
B) High resistance Absent Present
C) Absent end
diastolic flow
Absent Present
D) Reversal of end
diastolic flow
Absent Present
MIDDLE CEREBRAL
ARTERY
A) Pattern Normal Abnormal
B) Increased
diastolic flow
Absent Present
DELIVERY Vaginal Instrumental LSCS
CONDITION IUD Stillbirth Live birth
MATURITY term Preterm
APGAR 1 MIN ≥7/10 5/10 – 6/10 ≤4/10
APGAR 5 MIN ≥7/10 5/10 – 6/10 ≤4/10
NNC Death Without complication With  complication
STUDY GROUP
S.NO I.P. NO AGE PARITY UTERINE ARTERY UMBILICAL MCA DELIVERY COND ONDELIVERY MATURITY
APGAR
1MIN
APGAR
5 MIN NNCPATTERN HIGH RESI E.D.N PATTERN HIGH RESI AEDF REDF PATTERN IDF
1 7169 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
2 7148 2 1 2 2 2 2 2 2 2 2 2 3 3 1 2 2 3
3 71208 2 1 1 1 1 1 1 1 1 1 1 2 3 1 1 1 2
4 7223 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
5 7568 1 1 1 1 1 2 2 1 1 1 1 1 3 1 1 1 2
6 8117 2 1 1 1 1 2 2 2 2 1 1 3 3 1 3 2 3
7 8330 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
8 7998 2 1 1 1 1 2 2 2 2 2 2 3 3 2 3 2 3
9 9074 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
10 9234 2 1 1 1 1 2 2 2 1 1 1 1 3 1 1 1 2
11 9647 2 1 1 1 1 1 2 2 1 1 1 1 3 1 2 1 2
12 9879 2 1 2 2 2 2 2 2 2 2 2 3 3 2 2 2 1
13 10346 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
14 10239 2 1 1 1 1 2 2 2 1 1 1 1 3 1 2 1 2
15 10787 2 1 2 2 2 2 2 2 2 1 1 3 3 1 2 1 3
16 11237 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
17 11846 2 1 2 2 2 2 2 2 2 2 2 3 3 2 2 2 3
18 12076 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
19 12511 2 1 1 1 1 2 2 2 1 1 1 1 3 2 2 1 2
20 12277 2 1 1 1 1 2 2 2 2 1 1 3 3 1 1 1 2
21 12999 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
22 13112 2 1 1 1 1 2 2 2 1 1 1 1 3 1 2 1 2
23 13981 3 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
24 13746 2 1 2 2 2 2 2 2 2 2 2 1 1 2 3 3 1
25 14486 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
26 14703 2 1 2 2 2 2 2 2 2 1 1 3 3 2 2 2 3
27 14896 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
28 15301 2 1 2 2 2 2 2 2 2 2 2 3 3 2 2 2 1
29 15673 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
30 15871 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
31 16298 2 1 1 1 1 2 2 2 1 1 1 1 3 1 2 1 2
32 16906 1 1 2 2 2 2 2 2 2 1 1 3 3 2 2 2 3
33 17030 2 1 1 1 1 2 2 2 2 2 2 3 3 2 3 2 3
34 17740 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
S.NO I.P. NO AGE PARITY UTERINE ARTERY UMBILICAL MCA DELIVERY COND ONDELIVERY MATURITY
APGAR
1MIN
APGAR
5 MIN NNCPATTERN HIGH RESI E.D.N PATTERN HIGH RESI AEDF REDF PATTERN IDF
35 17871 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
36 18901 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
37 18534 2 1 1 1 1 2 2 2 1 1 1 1 3 1 2 1 2
38 18739 1 1 2 2 2 2 2 2 2 2 2 3 3 2 3 2 1
39 19478 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
40 19978 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
41 20278 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
42 20987 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
43 20411 1 1 2 2 2 2 2 2 2 1 1 3 3 1 2 2 3
44 21009 2 1 2 2 2 2 2 2 2 1 1 3 3 2 2 2 3
45 21986 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
46 22010 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
47 22876 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
48 23007 2 1 1 1 1 2 2 2 1 1 1 3 3 1 1 1 2
49 23497 2 1 2 2 2 2 2 2 2 2 2 1 1 2 3 3 1
50 23567 2 1 1 1 1 2 2 2 1 1 1 1 3 1 2 1 2
51 24111 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
52 24998 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
53 25789 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
54 25376 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
55 25972 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
56 26746 2 1 2 2 2 2 2 2 2 1 1 3 3 1 2 2 3
57 26431 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
58 27128 3 1 1 1 1 1 1 1 1 1 1 1 3 1 2 1 2
59 27340 2 1 2 2 2 2 2 2 2 1 1 3 3 1 2 2 3
60 27870 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
61 28543 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
62 28289 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
63 29012 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
64 29478 2 1 1 1 1 2 2 1 1 1 1 1 3 1 2 1 2
65 29843 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
66 30236 2 1 2 2 2 2 2 2 1 1 1 3 3 1 2 1 2
67 30012 2 1 2 2 2 2 2 2 2 2 2 3 3 2 3 2 3
68 29568 2 1 1 1 1 2 2 2 2 1 1 3 3 1 2 1 2
69 29238 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
70 30446 2 1 2 2 2 2 2 2 2 2 2 1 1 2 3 3 1
S.NO I.P. NO AGE PARITY UTERINE ARTERY UMBILICAL MCA DELIVERY COND ONDELIVERY MATURITY
APGAR
1MIN
APGAR
5 MIN NNCPATTERN HIGH RESI E.D.N PATTERN HIGH RESI AEDF REDF PATTERN IDF
71 30786 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
72 30989 2 1 1 1 1 2 2 2 1 1 1 3 3 1 2 1 2
73 30886 2 1 2 2 2 2 2 2 2 2 2 3 2 2 3 3 1
74 30647 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
75 31478 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
76 31198 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
77 31374 2 1 1 1 1 2 2 2 1 1 1 3 3 1 1 1 2
78 31621 2 1 2 2 2 2 2 2 2 2 2 3 3 2 3 2 3
79 31945 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
80 32128 2 1 2 2 2 2 2 2 2 1 1 3 3 1 2 2 3
81 32377 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
82 32546 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
83 32647 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
84 32978 2 1 2 2 2 2 2 2 1 1 1 3 3 1 2 1 2
85 33768 2 1 1 1 1 2 2 2 2 2 2 3 2 2 3 3 1
86 33236 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
87 33576 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
88 33898 2 1 2 2 2 2 2 2 2 1 1 3 3 1 3 2 3
89 33976 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
90 34121 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
91 34591 1 1 2 2 2 2 2 2 2 2 2 1 1 2 3 3 1
92 34999 2 1 2 2 2 2 2 2 1 1 1 3 3 1 2 1 2
93 34784 2 1 2 2 2 2 2 2 1 1 1 3 3 1 2 1 2
94 34437 2 1 1 1 2 2 2 2 1 1 1 3 3 1 2 1 2
95 35730 2 1 2 2 2 2 2 2 2 1 1 3 3 2 3 2 3
96 35227 2 1 2 2 2 2 2 2 2 2 2 3 3 2 3 2 3
97 35189 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
98 36440 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
99 36101 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
100 36841 2 1 1 1 1 1 1 1 1 2 2 1 3 1 1 1 2
CONTROL GROUP
S.NO I.P. NO AGE PARITY UTERINE ARTERY UMBILICAL MCA DELIVERY COND ONDELIVERY MATURITY
APGAR
1MIN
APGAR
5 MIN NNCPATTERN HIGH RESI E.D.N PATTERN HIGH RESI AEDF REDF PATTERN IDF
1 7251 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
2 7133 1 1 1 1 1 1 1 1 1 1 1 2 3 1 1 1 2
3 7122 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
4 7168 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
5 6956 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
6 7892 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
7 8447 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
8 8170 2 1 1 1 1 1 1 1 1 1 1 1 3 2 2 1 2
9 8798 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
10 8609 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
11 9476 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
12 10010 2 1 1 1 1 1 1 1 1 1 1 1 2 1 3 3 1
13 10127 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
14 10567 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
15 11011 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
16 11512 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
17 11348 2 1 1 1 1 1 1 1 1 1 1 2 3 1 1 1 2
18 11986 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
19 12121 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
20 12378 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
21 12874 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
22 13004 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
23 13443 1 1 1 1 1 1 1 1 1 1 1 3 3 2 2 1 2
24 13606 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
25 14371 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
26 14102 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
27 14909 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
28 15111 2 1 1 1 1 1 1 1 1 1 1 2 3 1 1 1 2
29 15547 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
30 15986 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
31 16100 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
32 16746 3 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
33 16547 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
34 17317 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
S.NO I.P. NO AGE PARITY UTERINE ARTERY UMBILICAL MCA DELIVERY COND ONDELIVERY MATURITY
APGAR
1MIN
APGAR
5 MIN NNCPATTERN HIGH RESI E.D.N PATTERN HIGH RESI AEDF REDF PATTERN IDF
35 17671 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
36 17498 2 1 1 1 1 1 1 1 1 1 1 1 3 2 3 2 3
37 18870 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
38 18470 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
39 19207 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
40 19530 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
41 19411 2 1 1 1 1 1 1 1 1 1 1 2 3 1 1 1 2
42 20107 2 1 1 1 1 1 1 1 1 1 1 1 3 2 1 1 2
43 20561 2 1 1 1 1 1 1 1 1 1 1 1 1 1 3 3 2
44 21199 1 1 1 1 1 1 1 1 1 1 1 3 3 2 1 1 2
45 21311 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
46 21576 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
47 22276 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
48 22494 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
49 23197 3 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
50 23301 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
51 23798 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
52 24674 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
53 24476 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
54 25196 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
55 25498 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
56 25863 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
57 26013 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
58 26987 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
59 27078 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
60 27490 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
61 27173 2 1 1 1 1 1 1 1 1 1 1 2 3 1 1 1 2
62 27986 2 1 1 1 1 1 1 1 1 1 1 3 3 2 1 1 2
63 28196 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
64 28765 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
65 29346 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
66 29769 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
67 29627 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
68 29981 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
69 30233 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
70 30601 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
S.NO I.P. NO AGE PARITY UTERINE ARTERY UMBILICAL MCA DELIVERY COND ONDELIVERY MATURITY
APGAR
1MIN
APGAR
5 MIN NNCPATTERN HIGH RESI E.D.N PATTERN HIGH RESI AEDF REDF PATTERN IDF
71 30176 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
72 30596 2 1 1 1 1 1 1 1 1 1 1 1 3 2 1 1 2
73 31078 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
74 31348 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
75 31127 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
76 31396 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
77 32274 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
78 31578 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
79 31899 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
80 32473 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
81 32078 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
82 33107 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
83 32814 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
84 33178 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
85 33489 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
86 34072 3 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
87 34192 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
88 34546 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
89 34303 2 1 1 1 1 1 1 1 1 1 1 3 3 2 2 2 2
90 33701 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
91 34671 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
92 35010 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
93 34371 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
94 34123 2 1 1 1 1 1 1 1 1 1 1 3 3 1 2 1 2
95 35517 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
96 35496 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
97 35312 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
98 36611 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
99 36445 2 1 1 1 1 1 1 1 1 1 1 3 3 1 1 1 2
100 36938 2 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 2
